Rockwell Medical Inc. [NASDAQ: RMTI] traded at a low on 10/21/20, posting a -3.81 loss after which it closed the day’ session at $1.01. The company report on October 13, 2020 that Rockwell Medical, Inc. Announces Presentations at the American Society of Nephrology Virtual Kidney Week 2020.
Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that two abstracts have been accepted for poster presentation at the American Society of Nephrology (ASN) Virtual Kidney Week 2020, which will occur from October 20 to 25, 2020.
Title: Use of Triferic and Outcomes of HDD Patients: Initial Analysis Using 2016-2017 USRDSPresenter: Yi Zhang, Ph.D., Sr. Research Associate, Medical Technology and Practice Patterns InstituteSession Title: Hemodialysis and Frequent Dialysis – 4E-Poster Number: PO1213Abstract Number: 3450928.
The results of the trading session contributed to over 1897548 shares changing hands. Over the past one week, the price volatility of Rockwell Medical Inc. stands at 3.55% while the volatility over the past one month is 5.46%.
The market cap for RMTI stock reached $92.09 million, with 69.43 million shares outstanding and 58.60 million shares in the current float. Compared to the average trading volume of 1.74M shares, RMTI reached a trading volume of 1897548 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Rockwell Medical Inc. [RMTI]?
Piper Jaffray have made an estimate for Rockwell Medical Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on June 24, 2019. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on May 13, 2019, representing the official price target for Rockwell Medical Inc. stock.
The Average True Range (ATR) for Rockwell Medical Inc. is set at 0.08, with the Price to Sales ratio for RMTI stock in the period of the last 12 months amounting to 1.47. The Price to Book ratio for the last quarter was 4.39, with the Price to Cash per share for the same quarter was set at 0.44.
How has RMTI stock performed recently?
Rockwell Medical Inc. [RMTI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.34. With this latest performance, RMTI shares dropped by -39.88% in over the last four-week period, additionally sinking by -56.28% over the last 6 months – not to mention a drop of -58.26% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RMTI stock in for the last two-week period is set at 34.70, with the RSI for the last a single of trading hit 31.27, and the three-weeks RSI is set at 37.39 for Rockwell Medical Inc. [RMTI]. The present Moving Average for the last 50 days of trading for this stock 1.2724, while it was recorded at 1.0620 for the last single week of trading, and 2.0175 for the last 200 days.
Rockwell Medical Inc. [RMTI]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Rockwell Medical Inc. [RMTI] shares currently have an operating margin of -55.62 and a Gross Margin at +4.63. Rockwell Medical Inc.’s Net Margin is presently recorded at -55.67.
Return on Total Capital for RMTI is now -132.07, given the latest momentum, and Return on Invested Capital for the company is -138.23. Return on Equity for this stock declined to -143.41, with Return on Assets sitting at -70.46. When it comes to the capital structure of this company, Rockwell Medical Inc. [RMTI] has a Total Debt to Total Equity ratio set at 19.87. Additionally, RMTI Total Debt to Total Capital is recorded at 16.58, with Total Debt to Total Assets ending up at 9.11. Long-Term Debt to Equity for the company is recorded at 8.76, with the Long-Term Debt to Total Capital now at 7.31.
Reflecting on the efficiency of the workforce at the company, Rockwell Medical Inc. [RMTI] managed to generate an average of -$114,141 per employee. Receivables Turnover for the company is 10.61 with a Total Asset Turnover recorded at a value of 1.27.Rockwell Medical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.10 and a Current Ratio set at 4.50.
Earnings analysis for Rockwell Medical Inc. [RMTI]
With the latest financial reports released by the company, Rockwell Medical Inc. posted -0.12/share EPS, while the average EPS was predicted by analysts to be reported at -0.16/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 25.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RMTI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Rockwell Medical Inc. go to 38.00%.
Insider trade positions for Rockwell Medical Inc. [RMTI]
There are presently around $15 million, or 41.70% of RMTI stock, in the hands of institutional investors. The top three institutional holders of RMTI stocks are: BLACKROCK INC. with ownership of 4,603,233, which is approximately 8.186% of the company’s market cap and around 1.50% of the total institutional ownership; VANGUARD GROUP INC, holding 3,156,025 shares of the stock with an approximate value of $3.19 million in RMTI stocks shares; and PERKINS CAPITAL MANAGEMENT INC, currently with $0.98 million in RMTI stock with ownership of nearly 29.93% of the company’s market capitalization.
Positions in Rockwell Medical Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 38 institutional holders increased their position in Rockwell Medical Inc. [NASDAQ:RMTI] by around 1,168,342 shares. Additionally, 31 investors decreased positions by around 774,578 shares, while 24 investors held positions by with 12,912,153 shares. The mentioned changes placed institutional holdings at 14,855,073 shares, according to the latest SEC report filing. RMTI stock had 14 new institutional investments in for a total of 186,327 shares, while 13 institutional investors sold positions of 198,274 shares during the same period.